Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

Norton, Nicholas J; Fun, Axel; Bandara, Mikaila; Wills, Mark R; Mok, Hoi Ping; Lever, Andrew M L

Norton, Nicholas J; Fun, Axel; Bandara, Mikaila; Wills, Mark R; Mok, Hoi Ping; Lever, Andrew M L.

Affiliation

Norton NJ; Department of Medicine, University of Cambridge, Cambridge, UK.
Fun A; Department of Medicine, University of Cambridge, Cambridge, UK.
Bandara M; Department of Medicine, University of Cambridge, Cambridge, UK.
Wills MR; Department of Medicine, University of Cambridge, Cambridge, UK.
Mok HP; Department of Medicine, University of Cambridge, Cambridge, UK. hpm22@cam.ac.uk.
Lever AML; Department of Medicine, University of Cambridge, Cambridge, UK. amll1@medschl.cam.ac.uk.

Retrovirology ; 14(1): 58, 2017 12 21.

Article in En | MEDLINE | ID: mdl-29268753

Subject(s)

CD4-Positive T-Lymphocytes/virology; Clinical Laboratory Techniques/trends; HIV Infections/virology; HIV-1/physiology; Viral Load; Virus Latency; Anti-HIV Agents/administration & dosage; Anti-HIV Agents/pharmacology; Clinical Trials as Topic; HIV Infections/drug therapy; HIV-1/drug effects; Humans; Reproducibility of Results

Key words

HIV; Latency; Viral outgrowth assay

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / HIV Infections / HIV-1 / Virus Latency / Viral Load / Clinical Laboratory Techniques Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Retrovirology Journal subject: VIROLOGIA Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google